Vegetables and fruits, rich in carotenoids and prostate cancer.

Prostate cancer risk: Data about the relation with prostate cancer risk was provided by one cohort of very small size. No association was found.
Prostate cancer mortality: No data was found.

Conclusion: No evidence was found for an association between carotene-rich vegetables or fruits and prostate cancer.

| More information: back to literature review.|


Author	Cohort name	Subjects	Years of follow-up	Cases	End point	Consumption of	Relative Risk (RR)	Adjustments
23) Ambrosini GL (2008)	No cohort name.	1985 blue asbestos-exposed men. (Australia)	Median 12.7 (1990-96 to 2004)	97	Prostate cancer incidence	Carotene-rich vegetables (carrot, sweet potato, pumpkin, bell peppers)	RR = 1.11 (0.56-2.20; P = 0.753) for the highest vs lowest tertile of consumption. Amount specific data (serves per week): 0-3.7: RR = 1. > 3.7-7.6: RR = 1.04 (0.59-1.83). > 7.6: RR = 1.11 (0.56-2.20).	Age, total fruit and vegetable intake, randomly assigned retinol or beta carotene supplement and source fo crocidolite exposure.
23) Ambrosini GL (2008)	No cohort name.	1985 blue asbestos-exposed men. (Australia)	Median 12.7 (1990-96 to 2004)	97	Prostate cancer incidence	Carotene-rich fruit (peaces, apricots, rockmelon)	RR = 1.14 (0.63-2.04; P = 0.667) for the highest vs lowest tertile of consumption. Amount specific data (serves per week): 0-0.8: RR = 1. > 0.8-2.6: RR = 1.04 (0.62-1.77). > 2.6: RR = 1.14 (0.63-2.04).	Age, total fruit and vegetable intake, randomly assigned retinol or beta carotene supplement and source fo crocidolite exposure.

Cancer & Diet. A systematic review.

Literature review.

Relating various aspects of our diet
to prostate cancer risk & mortality.

Vegetables and fruits, rich in carotenoids and prostate cancer.

Cancer & Diet. A systematic review.

Literature review.

Relating various aspects of our dietto prostate cancer risk & mortality.

Vegetables and fruits, rich in carotenoids and prostate cancer.

Relating various aspects of our diet
to prostate cancer risk & mortality.